IL-17 therapeutic blockade decreased Th1, Th17 cell populations and expression of CXCR3 among CD4+CCR6+CCR4+ and CD4+CCR6+CCR4− cell subsets in psoriasis patients. This evidence concerns the gene IL17A and psoriasis.